Literature DB >> 9588727

A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited.

F Buttgereit1, M Wehling, G R Burmester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9588727     DOI： 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  44 in total

1.  21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.

Authors:  M Paul-Clark; P Del Soldato; S Fiorucci; R J Flower; M Perretti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology.

Authors:  F Buttgereit; J A P da Silva; M Boers; G-R Burmester; M Cutolo; J Jacobs; J Kirwan; L Köhler; P Van Riel; T Vischer; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

Review 3.  [Cortisone therapy today].

Authors:  Hanns Kaiser
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

4.  Mesenchymal stromal cells versus betamethasone can dampen disease activity in the collagen arthritis mouse model.

Authors:  E S M El-Denshary; L A Rashed; M Elhussiny
Journal:  Clin Exp Med       Date:  2013-08-30       Impact factor: 3.984

5.  The inhibitory effect of dexamethasone on lymphocyte adhesion molecule expression and intercellular aggregation is not mediated by lipocortin 1.

Authors:  N J Goulding; S Ogbourn; N Pipitone; P Biagini; R Gerli; C Pitzalis
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 6.  [Glucocorticoid therapy in collagen diseases diseases].

Authors:  L Unger; M Kayser; M Enderlein; K Manger; H Nüsslein
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

7.  Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis.

Authors:  Mark J Paul-Clark; Lucia Mancini; Piero Del Soldato; Roderick J Flower; Mauro Perretti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

8.  Steroid withdrawal in renal transplant patients: the Irish experience.

Authors:  P J Phelan; A-M Moran; P O'Kelly; P Y Heng; S M Yussof; J J Walshe; C Magee; P J Conlon
Journal:  Ir J Med Sci       Date:  2010-10-29       Impact factor: 1.568

9.  Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Authors:  S Sipka; K Szucs; S Szántó; I Kovács; G Lakos; E Kiss; P Antal-Szalmás; G Szegedi; P Gergely
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

10.  Dexamethasone megadoses stabilize rat liver lysosomal membranes by non-genomic and genomic effects.

Authors:  B Hinz; R Hirschelmann
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.